Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228444 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 9 Pages |
Abstract
The thymidylate synthase genotype and XRCC1 Arg399Gln polymorphism might help to identify Stage II-III rectal cancer patients with a better outcome after preoperative concomitant chemoradiotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David M.D., Juliana Ph.D., Laia M.Sc., Lourdes M.D., Eduardo M.D., Elisabeth B.Sc., Agusti Ph.D., M.D., Eugenio M.D., Montserrat Ph.D.,